Estimated sales of major generic introductions in U.S. 2016
This statistic shows the estimated annual sales of major branded drugs that went generic in the United States during 2016. Allergy drug Nasonex (mometasone furoate monohydrate) generated annual sales of 956 million dollars in the United States in 2015. The first generic version of this drug was available on March 22, 2016.